
Ryan Tedford, MD, discusses his analysis of the phase 2 CADENCE trial, highlighting sotatercept’s beneficial effects on both the right and left sides of the heart.

Ryan Tedford, MD, is the Dr. Peter C. Gazes Endowed Chair in Heart Failure and professor of medicine/cardiology at the Medical University of South Carolina and the deputy editor of Circulation.

Ryan Tedford, MD, discusses his analysis of the phase 2 CADENCE trial, highlighting sotatercept’s beneficial effects on both the right and left sides of the heart.